US legalises sports betting: Here are the winners

Published 07-JUN-2018 15:14 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

After a long term ban, the US Supreme Court has cleared the way for US states to legalise betting on sports.

The Court struck down the 1992 federal law, the Professional and Amateur Sports Protection Act, which outlawed any gambling on sports outside of Nevada, meaning that any US state that wants sports gambling can now have it. Gamblers will be permitted to bet on single games and championships for a variety of professional sports including baseball, football, hockey, basketball, soccer, golf and auto racing.

Experts predict that gambling on sports could quickly become widely available across the US. One research firm estimates that 32 states would likely offer sports betting within five years, while Delaware’s legal sports wagering has already kicked off and many other states have laid the legal groundwork to have sports betting within weeks.

Already, Americans are believed to wager about $US150 billion (A$199B) on sports each year illegally, say the American Gaming Association — a figure that will almost certainly get a boost once betting is legalised across states.

This means there are going to be some winners, and I’m not talking about the gamblers themselves. The US federal government states are first in line, set to generate significant tax revenues from the change in legislation. Winning will be taxed as ordinary income at the individuals marginal tax rate .

The change in legislation will also pay off for listed gaming-related companies, which have already got a boost on US stock exchanges.

Casino stocks were particularly strong and many surged after the ruling was announced, including Penn National Gaming, Inc (NASDAQ:PENN) and Monarch Casino & Resort, Inc. (NASDAQ:MCRI).

In addition to casino operators, sports broadcasters such as Walt Disney Co (NYDE:DIS), MSG Networks (NYSE:MSGN) and CBS Corporation (NYSE:CBS), as well as equipment makers are expected to benefit from the ruling.

Australian online gaming and DFS firm PlayUp is confident that some of that enthusiasm can flow on as it prepare for its dual listing on the NASDAQ and ASX via a reverse takeover of Mission NewEnergy Limited (ASX:MBT | OTC:MNELF).

PlayUp intends to raise US40 million ($51.5 million) through the reverse listing on the ASX and deliver “the world’s first fully-integrated, blockchain enabled global fantasy sports, online sports betting & gaming ecosystem”.

It seems they couldn’t have timed it any better. New US legislation should now give PlayUp’s aspirations a boost.

The platform presently boasts over $550 million of annual transaction volume (Playup generates anywhere from 7c to 12c of every dollar) with 69,000 current paid users.

PlayUp has already locked in a number of acquisitions as it works towards its goal of becoming one of the largest fantasy sports platform operators. It has so far acquired online platform, betting.club, and CrownBet’s DraftStars, while it also has plans to buy Sydney-based ClassicBet.

PlayUp, which is understood to have 400,000 registered users, also plans to enter the cryptocurrency craze.

However, any news is speculative at this stage therefore investors considering this stock for their portfolio, should seek professional financial advice.

Mission NewEnergy has lodged disclosure documents to the ASX to approve the proposed transaction with PlayUp, however it is yet to make an announcement regarding the deal to as it works to determine the whether the company will be suitable for listing.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X